SXTC's 157.5 Million Registered Resale Shares Dwarf a 3.2 Million Tradeable Float

A single floorless convertible instrument held by one Hong Kong entity accounts for roughly 49 times the estimated free-trading supply of China SXT Pharmaceuticals shares, layered atop an undrawn $100 million at-the-market program and five reverse splits in five years.